Dmitriy N Feldman

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. doi Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 77:1020-30. 2011
  2. ncbi Innovations in drug-eluting stents
    K Nallu
    Division of Cardiology, Weill Cornell Medical College New York Presbyterian Hospital New York, New York, USA
    Panminerva Med 55:345-52. 2013
  3. doi Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)
    Dmitriy N Feldman
    Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, Greenberg Division of Cardiology, 520 E 70th St, Starr 434 Pavilion, New York, NY 10021, USA
    Circulation 127:2295-306. 2013
  4. ncbi Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selection
    B D Ghosh
    Department of Medicine, New York Presbyterian Hospital, New York, NY, USA
    Minerva Med 103:431-9. 2012
  5. doi Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 76:513-24. 2010
  6. doi Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA
    Am J Cardiol 105:323-32. 2010
  7. doi Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA
    Am J Cardiol 104:1210-5. 2009
  8. ncbi Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    J Invasive Cardiol 21:258-63. 2009
  9. ncbi Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY 10021, USA
    Am Heart J 154:695-701. 2007
  10. ncbi Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice
    Luke K Kim
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, New York, NY 10021, USA
    J Invasive Cardiol 22:94-100. 2010

Collaborators

Detail Information

Publications25

  1. doi Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 77:1020-30. 2011
    ..The aim of this meta-analysis was to assess the prevalence and prognostic value regarding mortality of cTnT or cTnI elevations after nonemergent percutaneous coronary intervention (PCI) in a large number of cohort/registry studies...
  2. ncbi Innovations in drug-eluting stents
    K Nallu
    Division of Cardiology, Weill Cornell Medical College New York Presbyterian Hospital New York, New York, USA
    Panminerva Med 55:345-52. 2013
    ..This comprehensive review will discuss the evolution of intracoronary stents from their introduction to current utilization of DES as well as future research on bioabsorbable stents and polymers. ..
  3. doi Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)
    Dmitriy N Feldman
    Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, Greenberg Division of Cardiology, 520 E 70th St, Starr 434 Pavilion, New York, NY 10021, USA
    Circulation 127:2295-306. 2013
    ..Our aims were to evaluate temporal trends in r-PCI and compare procedural outcomes between r-PCI and transfemoral PCI...
  4. ncbi Reperfusion therapy in ST-elevation myocardial infarction: guidelines, strategies, pharmacology, and stent selection
    B D Ghosh
    Department of Medicine, New York Presbyterian Hospital, New York, NY, USA
    Minerva Med 103:431-9. 2012
    ..This review will discuss the current STEMI guidelines and strategies, recent advances in pharmacotherapy, and data on stent selection...
  5. doi Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York 10021, USA
    Catheter Cardiovasc Interv 76:513-24. 2010
    ..This study sought to investigate if the efficacy of bivalirudin monotherapy is similar to heparin plus GP IIb/IIIa inhibition in patients with acute coronary syndromes (ACS) treated with clopidogrel following diagnostic angiography...
  6. doi Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes
    Dmitriy N Feldman
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA
    Am J Cardiol 105:323-32. 2010
    ..927). In conclusion, treatment with a 600-mg loading dose <2 hours before PCI is associated with similar short-term ischemic outcomes and long-term mortality compared to the currently recommended clopidogrel pretreatment regimen...
  7. doi Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA
    Am J Cardiol 104:1210-5. 2009
    ....
  8. ncbi Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention
    Dmitriy N Feldman
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    J Invasive Cardiol 21:258-63. 2009
    ....
  9. ncbi Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY 10021, USA
    Am Heart J 154:695-701. 2007
    ..We investigated whether long-term outcomes after bivalirudin use remained comparable to heparin plus GP IIb/IIIa blockade in current clinical practice of drug-eluting stent use...
  10. ncbi Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice
    Luke K Kim
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, 520 East 70th Street, New York, NY 10021, USA
    J Invasive Cardiol 22:94-100. 2010
    ..This study sought to evaluate the short- and long-term efficacy and safety of bivalirudin in diabetic patients undergoing percutaneous coronary intervention (PCI) in contemporary clinical practice...
  11. doi Nonsystem reasons for delay in door-to-balloon time and associated in-hospital mortality: a report from the National Cardiovascular Data Registry
    Rajesh V Swaminathan
    New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, New York, New York, USA
    J Am Coll Cardiol 61:1688-95. 2013
    ..The goal of this study was to characterize nonsystem reasons for delay in door-to-balloon time (D2BT) and the impact on in-hospital mortality...
  12. ncbi Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era
    Scott Midwall
    Greenberg Division of Cardiology, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York 10021, USA
    J Invasive Cardiol 25:132-6. 2013
    ..This study sought to compare short- and long-term (4-year) outcomes in patients with and without peripheral vascular disease (PVD) following non-emergent percutaneous coronary intervention (PCI) in current clinical practice...
  13. doi Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis
    Ehrin J Armstrong
    Division of Cardiology, University of California, Davis Medical Center, Sacramento, California 95817, USA
    JACC Cardiovasc Interv 5:131-40. 2012
    ..The aim of this study was to describe differences in treatment and in-hospital mortality of early, late, and very late stent thrombosis (ST)...
  14. pmc Outcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty
    Ashish Shah
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY 10021, USA
    Vasc Health Risk Manag 8:115-23. 2012
    ..These results further support the use of bivalirudin in the setting of primary PCI for STEMI given that its benefits are maintained through long-term follow-up...
  15. pmc Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers
    Robert M Minutello
    Department of Medicine, Division of Cardiology, Weill Cornell Medical College, New York, New York 10065, USA
    Tex Heart Inst J 37:161-5. 2010
    ....
  16. ncbi Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry)
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Am J Cardiol 99:446-9. 2007
    ..In conclusion, as currently practiced in New York State, the strategy of ad hoc PCI in selected patient cohorts appears to be as safe as the strategy of staged procedures...
  17. doi Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention
    Jonathan Gordin
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA
    Am J Cardiol 110:1397-404. 2012
    ..In patients with unstable coronary syndromes, long-term statin therapy may be beneficial, particularly at a high dose...
  18. doi Pharmacotherapy for the reduction of stent thrombosis
    David C Yang
    Weill Cornell Medical College, New York Presbyterian Hospital, Department of Medicine, Greenberg Division of Cardiology, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    Expert Rev Cardiovasc Ther 11:567-76. 2013
    ..In this review, evidence related to the various pharmacological agents for reduction of stent thrombosis available to clinicians during and after PCI will be explored...
  19. ncbi A strategy of 'treating through' a prasugrel-induced rash
    David C Yang
    Weill Medical College of Cornell University, Greenberg Division of Cardiology, New York, NY, United States
    Int J Cardiol . 2013
  20. doi Novel antiplatelet therapies
    Luke Kim
    Greenberg Division of Cardiology, New York Presbyterian Hospital, Weill Cornell Medical College, 520 East 70th Street, Starr 434 Pavilion, New York, NY 10021, USA
    Curr Atheroscler Rep 14:78-84. 2012
    ..The field of pharmacotherapy continues to rapidly evolve as newer agents, such as thrombin receptor antagonists, along with older agents, such as cilostazol and glycoprotein IIb/IIIa inhibitors, are being explored...
  21. ncbi Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Am J Cardiol 98:1334-9. 2006
    ..Elderly patients, in particular octogenarians undergoing emergency PCI, have a substantially higher risk of in-hospital death...
  22. ncbi Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease
    Robert M Minutello
    New York Presbyterian Hospital, Weill Cornell Campus, New York, New York, USA
    J Interv Cardiol 20:458-65. 2007
    ..The purpose of this study was to evaluate the efficacy of sirolimus-eluting stents (SES) in the treatment of saphenous vein graft (SVG) disease...
  23. doi Unplanned staged hybrid management of postmyocardial infarction ventricular septal defect
    Dimitrios V Avgerinos
    Department of Cardiothoracic Surgery, New York Presbyterian Hospital Weill Cornell Medical Center, New York, NY, USA
    Cardiology 118:38-41. 2011
    ..This case demonstrates the successful application of an unplanned, staged hybrid approach utilizing initial percutaneous and subsequent surgical repair after recovery of tissue integrity...
  24. ncbi Images in cardiology: macroscopic T-wave alternans
    Dmitriy N Feldman
    Division of Cardiology, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, New York, USA
    Clin Cardiol 29:422. 2006
  25. pmc Ruptured aneurysm of the right sinus of valsalva associated with a ventricular septal defect and an anomalous coronary artery
    Dmitriy N Feldman
    Division of Cardiology, Weill Medical College of Cornell University, 525 East 68th Street, New York, New York 1002, USA
    Tex Heart Inst J 32:555-9. 2005
    ..Previously published reports of the coexistence of a single coronary artery with a sinus of Valsalva aneurysm or with a ventricular septal defect, and their management, are discussed herein...